Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.73 billion. The enterprise value is $1.33 billion.

Market Cap	1.73B
Enterprise Value	1.33B

Important Dates

The last earnings date was Tuesday, March 3, 2026, after market close.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

ELVN has 59.80 million shares outstanding. The number of shares has increased by 20.38% in one year.

Current Share Class	59.80M
Shares Outstanding	59.80M
Shares Change (YoY)	+20.38%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	3.76%
Owned by Institutions (%)	65.27%
Float	34.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.97
P/TBV Ratio	3.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.66, with a Debt / Equity ratio of 0.00.

Current Ratio	28.66
Quick Ratio	27.92
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.95% and return on invested capital (ROIC) is -19.43%.

Return on Equity (ROE)	-26.95%
Return on Assets (ROA)	-18.65%
Return on Invested Capital (ROIC)	-19.43%
Return on Capital Employed (ROCE)	-26.04%
Weighted Average Cost of Capital (WACC)	10.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.16% in the last 52 weeks. The beta is 1.06, so ELVN's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+43.16%
50-Day Moving Average	26.02
200-Day Moving Average	21.62
Relative Strength Index (RSI)	58.43
Average Volume (20 Days)	694,530

Short Selling Information

The latest short interest is 7.98 million, so 13.34% of the outstanding shares have been sold short.

Short Interest	7.98M
Short Previous Month	8.08M
Short % of Shares Out	13.34%
Short % of Float	23.38%
Short Ratio (days to cover)	8.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-119.66M
Pretax Income	-103.69M
Net Income	-103.69M
EBITDA	-119.40M
EBIT	-119.66M
Earnings Per Share (EPS)	-$1.83

Balance Sheet

The company has $462.62 million in cash and $399,000 in debt, with a net cash position of $462.22 million or $7.73 per share.

Cash & Cash Equivalents	462.62M
Total Debt	399,000
Net Cash	462.22M
Net Cash Per Share	$7.73
Equity (Book Value)	459.60M
Book Value Per Share	7.73
Working Capital	458.31M

Cash Flow

In the last 12 months, operating cash flow was -$70.30 million and capital expenditures -$158,000, giving a free cash flow of -$70.46 million.

Operating Cash Flow	-70.30M
Capital Expenditures	-158,000
Free Cash Flow	-70.46M
FCF Per Share	-$1.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.38%
Shareholder Yield	-20.38%
Earnings Yield	-5.79%
FCF Yield	-3.94%

Analyst Forecast

The average price target for ELVN is $41.00, which is 41.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.00
Price Target Difference	41.53%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2